Alan Minsk and Laura LaBrie Discuss FDA Advertising and Promotion on FDA Watch Podcast

AGG Food & Drug attorneys Alan Minsk and Laura LaBrie joined the FDA Watch Podcast for the third installment of its Legal, Regulatory, & Compliance Series with AGG.

During the episode, “FDA Legal, Regulatory & Compliance Issues, Part 3: Advertising & Promotion,” Alan and Laura discuss recent actions by FDA’s Office of Prescription Drug Promotion (“OPDP”) involving direct-to-consumer advertising, as well as the role of artificial intelligence in OPDP enforcement and companies’ promotional review processes.

The conversation also addresses considerations for companies responding to competitor promotion and advertising and promotion topics that could receive greater FDA attention in 2027.

To listen to the full episode, please click here.